Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25
Pfs25 is a transmission-blocking vaccine candidate for Plasmodium. Here, McLeod et al. analyze the antibody response to Pfs25 in sera from a clinical trial evaluating a Pfs25 vaccine candidate, identify a potent transmission-blocking antibody and determine recognized epitopes on Pfs25.
Enregistré dans:
Auteurs principaux: | Brandon McLeod, Kazutoyo Miura, Stephen W. Scally, Alexandre Bosch, Ngan Nguyen, Hanjun Shin, Dongkyoon Kim, Wayne Volkmuth, Sebastian Rämisch, Jessica A. Chichester, Stephen Streatfield, Colleen Woods, William R. Schief, Daniel Emerling, C. Richter King, Jean-Philippe Julien |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/67758bcac9e4447fab4577c5f6b5c7a0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
par: Stephen W. Scally, et autres
Publié: (2017) -
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45
par: Prasun Kundu, et autres
Publié: (2018) -
A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria
par: Tarlan Mamedov, et autres
Publié: (2019) -
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
par: Frank Lennartz, et autres
Publié: (2018) -
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
par: Yimin Wu, et autres
Publié: (2008)